Kelly Tatham

After completing degree in Medicinal and pharmaceutical Chemistry at The University of Loughborough in 1998 Kelly joined the Analytical Development department in AstraZeneca R&D.  AstraZeneca is a world leading pharmaceutical company which develops new drugs in the following disease areas: Cancer, Cardiovascular, Gastrointestinal, Infection, Neuroscience and Respiratory & Inflammation.

The Analytical Development department is involved in the development of new drug formulations (e.g. tablets, inhalers, injectables etc) and the department focuses on the quality testing and stability of the formulations using analytical techniques.  In particular she is experienced in chromatographic techniques, delivery of analytical targets during different phases of development and compliance with legal requirements for pharmaceuticals.  She is also gaining experience in the use of design of experiments and statistics.

Kelly can answer questions on Chemistry and Analytical chemistry/science.

Laura Downes

After completing degree in Chemistry at The University of Birmingham in 1998 Laura joined the Analytical Development department in AstraZeneca R&D. AstraZeneca is a world leading pharmaceutical company which develops new drugs in the following disease areas: Cancer, Cardiovascular, Gastrointestinal, Infection, Neuroscience and Respiratory & Inflammation.

The Analytical Development department is involved in the development of new drug formulations (e.g. tablets, inhalers, injectables etc) and the department focuses on the quality testing and stability of the formulations using analytical techniques. In particular she is experienced in chromatographic techniques, delivery of analytical targets during different phases of development and compliance with legal requirements for pharmaceuticals.

She also has experience in the coaching of industrial placement students during their year within Analytical Development. She can answer questions about chemistry, analytical chemistry and science.